Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-563-2 | CAS number: 6610-29-3
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Experimental toxicokinetic studies were not available. However, as per REACH guidance document R7.C (May 2008), information on absorption, distribution, metabolisation and excretion may be deduced from the physicochemical properties. MTSC seems to be weel absorbed by oral and dermal route, and well distributed in the organism, due to the liver toxicity observed after repeated oral exposure. An excretion of MTSC via urine is expected.
Key value for chemical safety assessment
Additional information
The following remarks on the toxicokinetics of 4 -methylthiosemicarbazide (MTSC) are based on the available studies. Experimental toxicokinetic studies were not available. However, as per REACH guidance document R7.C (May 2008), information on absorption, distribution, metabolisation and excretion may be deduced from the physicochemical properties, including:
-Molecular weight: 105.16 g/mol
-Water solubility: 40.2 g/L (20°C), MTSC is highly soluble in water.
-Partition coefficient Log Kow: -1.21
-Vapour pressure: 0.0000069 Pa (25°C)
ABSORPTION
The physicochemical characteristics of MTSC (high water solubility) and the molecular mass (105.16 g/mol) are in the range suggestive of absorption after oral and dermal exposure. The assumption of an oral absorption is confirmed by the data acute oral toxicity with a very low LD50 in rats (15 mg/kg bw in rat). MTSC is toxic by oral route. Dermal absorption of MTSC is also confirmed by the data acute dermal toxicity (LD50 between 200 and 1000 mg/kg bw in rat).
According to the value of the low vapour pressure, MTSC is not expected to be a volatile substance.
DISTRIBUTION and METABOLISM
As a small molecule a wide distribution of MTSC is expected. This assumption is confirmed by the changes shown in the repeated dose toxicity studies following oral application: effects on thymus and spleen at 10 mg/kg bw/d in rats after 28-day exposure were specific to the oral administration of MTSC in rats.
No specific information was found on metabolism of MTSC.
EXCRETION
MTSC is probably excreted in the urine, because it is a water-soluble substance with a low molecular weight (below 300); and generally, they are conjugated metabolites from Phase II biotransformation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
